Symbol
Aclaris Therapeutics, Inc.
Full name of the company.
MEDICAL-DRUGS
Industry name
DRUGS
Major industry name
Medical
Sector name
$1.40
Current price of the stock
$812K
Trading volume of the stock
$99.9M
Market capitalization of the company
Micro Cap
Category of market capitalization
-
Long-term growth mean estimate
4.71
Mean analyst rating
602.36%
Potential price appreciation based on analyst price targets
68.75%
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
7.03
Current ratio
44.59%
Gross profit margin
-240.93%
Operating profit margin
-240.93%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-174.55%
Pretax profit margin
-174.55%
Net profit margin
-5.83%
Measures profitability relative to shareholders' equity
-5.83%
ROE excluding intangible assets
-4.16%
Measures profitability relative to total assets
-5.83%
Measures profitability relative to invested capital
0.02
Asset turnover ratio
-
Inventory turnover ratio
12.67
Receivables turnover ratio
7.10
Average number of days it takes to collect receivables
-2.69
Measures valuation relative to earnings
-
P/E based on future earnings estimates
3.69
Measures valuation relative to sales
0.77
Measures valuation relative to book value
-0.69
Measures valuation relative to operating cash flow
-0.68
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
